Paula R Pohlmann

Trials

Studies that name Paula R Pohlmann as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:41 UTC. Open this list on ClinicalTrials.gov

• Ph1/Ph2
  NCT05868226 · PRE-ISPY Phase I/II Oncology Platform Program

  QuantumLeap Healthcare Collaborative · recruiting · HER2-positive Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer · principal investigator
• Ph1
  NCT04602117 · ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer

  QuantumLeap Healthcare Collaborative · withdrawn · HER2-positive Breast Cancer, HER2 Low, SYD-985 · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-11 23:41 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.